In conclusion, the results demonstrate that aberrant methylation of p16INK4a promoter was associated with human ovarian cancer, suggesting that promoter methylation of p16INK4a plays a crucial role in human ovarian cancer. The gene discussed is CDKN2A; the disease is ovarian carcinoma.